Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)

Spremljeno u:
Bibliografski detalji
Izdano u:Cardiovasc Drugs Ther
Glavni autori: Judge, Daniel P., Kristen, Arnt V., Grogan, Martha, Maurer, Mathew S., Falk, Rodney H., Hanna, Mazen, Gillmore, Julian, Garg, Pushkal, Vaishnaw, Akshay K., Harrop, Jamie, Powell, Christine, Karsten, Verena, Zhang, Xiaoping, Sweetser, Marianne T., Vest, John, Hawkins, Philip N.
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2020
Teme:
Correction
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7852847/
https://ncbi.nlm.nih.gov/pubmed/32548685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-020-07023-8
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items